EUVIMEDSkopri EUVIMED
Crossref

Adaptive designs in public health: Vaccine and cluster randomized trials go Bayesian

Ofir Harari iD, Jay J H Park, Prince Kumar Lat, Edward J Mills

Statistics in Medicine · 2024

DOI: 10.1002/sim.10104 ↗

At a glance

Journal article in Statistics in Medicine, 2024. Written by Ofir Harari and 3 co-authors. Institution: Core Clinical Sciences, Vancouver, British Columbia, Canada. Major MEDLINE topics: Bayes Theorem, Randomized Controlled Trials as Topic, Public Health, Vaccines. Cited 2 times so far (Crossref); 38 references. Funded by: NIA NIH HHS, NIEHS NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Clinical trials in public health—particularly those conducted in low‐ and middle‐income countries—often involve communicable and non‐communicable diseases with high disease burden and unmet needs. Trials conducted in these regions often are faced with resource limitations, so improving the efficiencies of these trials is critical. Adaptive trial designs have the potential to save trial time and resources and reduce the number of patients receiving ineffective interventions. In this paper, we provide a detailed account of the implementation of vaccine and cluster randomized trials within the framework of Bayesian adaptive trials, with emphasis on computational efficiency and flexibility with regard to stopping rules and allocation ratios. We offer an educated approach to selecting prior distributions and a data‐driven empirical Bayes method for plug‐in estimates for nuisance parameters.

Subjects

MeSH terms (MEDLINE)

Bayes TheoremRandomized Controlled Trials as TopicPublic HealthVaccinesHumansResearch DesignCluster AnalysisAdaptive Clinical Trials as Topic

Author keywords

Bayesian adaptive designglobal health

Substances

Vaccines

Authors and institutions

  • Core Clinical Sciences, Vancouver, British Columbia, Canada.
  • Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Biostatistics, Purpose Life Sciences, Vancouver, British Columbia, Canada.
  • Purpose Life Sciences, Vancouver, British Columbia, Canada.

ORCID profiles: Ofir Harari

Funding

  • NIA NIH HHS
  • NIEHS NIH HHS

Cite

APA

Harari, O., Park, J. J. H., Lat, P. K., & Mills, E. J. (2024). Adaptive designs in public health: Vaccine and cluster randomized trials go Bayesian. Statistics in Medicine. https://doi.org/10.1002/sim.10104

Vancouver

Harari O, Park JJH, Lat PK, Mills EJ. Adaptive designs in public health: Vaccine and cluster randomized trials go Bayesian. Statistics in Medicine. 2024. doi:10.1002/sim.10104

BibTeX
@article{Harari2024,
  author = {Harari, Ofir and Park, Jay J H and Lat, Prince Kumar and Mills, Edward J},
  title = {Adaptive designs in public health: Vaccine and cluster randomized trials go Bayesian},
  journal = {Statistics in Medicine},
  year = {2024},
  doi = {10.1002/sim.10104}
}
Start for free →